Screening test of Fabry disease by pain in children

Screening test of Fabry disease by pain in children - Screening test in Fabry disease

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015625

Enrollment

100

Registered

2014-11-10

Start date

2014-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fabry disease

Interventions

If the levels of plasma Lyso-Gb3 was higher than the normal levels.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pediatric patients developed pain

Exclusion criteria

Exclusion criteria: Not to be able to obtain the informed coscent

Design outcomes

Primary

Measure	Time frame
To detect the patients with Fabry disease in their early stages.	—

Countries

Japan

Contacts

Public ContactHitoshi Yamamoto

St. Marianna University School of Medicine Department of Pediatrics

h3yama@marianna-u.ac.jp044-977-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026